Innovus Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$3.95 |
Market Cap |
$4.07 M |
Shares Outstanding |
2.62 M |
Public Float |
1.89 M |
Address |
8845 Rehco Road San Diego California 92122 United States |
Employees | - |
Website | http://www.innovuspharma.com |
Updated | 07/08/2019 |
Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. It also provides packaged healthcare solutions through over-the-counter, medicines and consumer and health products, which it market directly or through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through on-line channels, retailers and wholesalers. The company business model leverages the ability to acquire and in-license commercial products that are supported by scientific, and or clinical evidence, place them through it existing supply chain, retail and on-line channels. |